Table 2

Binding affinities of BZD site ligands for myc-tagged γ2, γ2 A79 mutants, and γ2 T81 mutants

ReceptorFlunitrazepamRo15-4513Ro15-1788
KInKI-mut/KI-αβγKInKI-mut/KI-αβγKInKI-mut/KI-αβγ
nM nM nM
αβγmyc 8.9  ± 0.931.03.9  ± 0.961.03.5  ± 0.231.0
αβγA79R24.3  ± 5.42-150 32.75.6  ± 1.631.45.6  ± 0.831.6
αβγA79C47.6  ± 5.32-150 35.362.1  ± 15.42-150 315.920.3  ± 1.12-150 35.8
αβγA79Y6.1  ± 2.230.7201.5  ± 25.72-150 351.774.1  ± 10.62-150 321.2
αβγA79Q79.5  ± 12.62-150 38.9112.2  ± 31.72-150 328.864.7  ± 12.52-150 318.5
αβγT81S14.2  ± 2.731.64.2  ± 2.061.16.8  ± 1.02-150 41.9
αβγT81A8.2  ± 0.930.917.0  ± 4.92-150 44.44.1  ± 0.331.2
αβγT81C32.8  ± 7.62-150 33.716.9  ± 7.12-150 44.38.7  ± 1.72-150 32.5

Ro15-4513 KI values for αβγmyc and αβγT81 mutant receptors were determined by homologous competition radioligand binding assays. All other KI values were determined by displacement of [3H]flunitrazepam binding. Results shown are the mean ± S.E.; n is the number of independent experiments. Statistical differences between logKI values were determined by one-way ANOVA using Dunnett's post-test.

  • 2-150  Significantly different from αβγmyc(P < .01).